Citigroup Inc Glaukos Corp Transaction History
Citigroup Inc
- $190 Billion
- Q1 2025
A detailed history of Citigroup Inc transactions in Glaukos Corp stock. As of the latest transaction made, Citigroup Inc holds 77,546 shares of GKOS stock, worth $7.52 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77,546
Previous 80,952
4.21%
Holding current value
$7.52 Million
Previous $12.1 Million
37.12%
% of portfolio
0.0%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding GKOS
# of Institutions
358Shares Held
50.2MCall Options Held
260KPut Options Held
776K-
Black Rock Inc. New York, NY8.04MShares$779 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$578 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.29MShares$222 Million0.04% of portfolio
-
State Street Corp Boston, MA1.98MShares$192 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.94MShares$189 Million0.05% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.62B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...